KATHRYN OLIVER: Open Payments
NPI 1720394109 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 54 payments from 13 companies in 2025. Trend: 2023 $2,192 · 2024 $342 · 2025 $1,044
Food & beverage: $1,033Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| ABBVIE INC. | 15 | $195 |
| Novo Nordisk Inc | 9 | $155 |
| Janssen Pharmaceuticals, Inc | 5 | $110 |
| SHIELD THERAPEUTICS INC | 4 | $86 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $31 |
| Dexcom, Inc. | 1 | $23 |
Products named: AIRSUPRA, SPRAVATO, ACCRUFER, UBRELVY, TZIELD, VRAYLAR, Ozempic, QULIPTA.
Industry payments across MN — which companies pay providers there.
